Literature DB >> 2391481

The role of ethanol abuse in the etiology of heroin-related death.

A J Ruttenber1, H D Kalter, P Santinga.   

Abstract

Toxicology analyses and other forensic science data were used to examine the mechanisms through which ethanol increased the risk for death caused by injected street preparations of heroin. The authors studied 505 victims of fatal heroin overdose and compared subjects who had concentrations of blood ethanol greater than 1000 mg/L (n = 306) with those who had concentrations less than, or equal to 1000 mg/L (n = 199). We found significant negative correlations between concentrations of ethanol and morphine (a heroin metabolite) in blood (R2 = 0.11, P = 0.0001 for log10-transformed variables) as well as between concentrations of blood ethanol and bile morphine (R2 = 0.16, P = 0.0001 for log10 bile morphine versus blood morphine). Toxicologic evidence of infrequent heroin use was more common in decedents with blood ethanol concentrations greater than 1000 mg/L than in those with lower concentrations. Our data suggest that ethanol enhances the acute toxicity of heroin, and that ethanol use indirectly influences fatal overdose through its association with infrequent (nonaddictive) heroin use and thus with reduced tolerance to the acute toxic effects of heroin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391481

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  11 in total

1.  Heroin-related deaths in Sydney, Australia. How common are they?

Authors:  T M Garrick; D Sheedy; J Abernethy; A E Hodda; C G Harper
Journal:  Am J Addict       Date:  2000

Review 2.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

3.  Links between suicidal intent, polysubstance use, and medical treatment after non-fatal opioid overdose.

Authors:  Rachel E Gicquelais; Mary Jannausch; Amy S B Bohnert; Laura Thomas; Srijan Sen; Anne C Fernandez
Journal:  Drug Alcohol Depend       Date:  2020-05-16       Impact factor: 4.492

4.  Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Giulia Scuppa; Andrea Cippitelli; Lawrence Toll; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-08       Impact factor: 4.492

5.  Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neurons.

Authors:  Javier Llorente; Sarah Withey; Guadalupe Rivero; Margaret Cunningham; Alex Cooke; Kunal Saxena; Jamie McPherson; Sue Oldfield; William L Dewey; Chris P Bailey; Eamonn Kelly; Graeme Henderson
Journal:  Mol Pharmacol       Date:  2013-05-28       Impact factor: 4.436

6.  Temporal correlation between opiate seizures in East/Southeast Asia and B.C. heroin deaths: a transoceanic model of heroin death risk.

Authors:  Mark E McLean
Journal:  Can J Public Health       Date:  2003 Sep-Oct

7.  Less glucuronidation of morphine in the presence of ethanol in vivo.

Authors:  Gudrun Høiseth; Jannike Mørch Andersen; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2013-06-06       Impact factor: 2.953

Review 8.  Heroin overdose: research and evidence-based intervention.

Authors:  Shane Darke; Wayne Hall
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

9.  Ethanol Reversal of Tolerance to the Respiratory Depressant Effects of Morphine.

Authors:  Rob Hill; Abi Lyndon; Sarah Withey; Joanne Roberts; Yvonne Kershaw; John MacLachlan; Anne Lingford-Hughes; Eamonn Kelly; Chris Bailey; Matthew Hickman; Graeme Henderson
Journal:  Neuropsychopharmacology       Date:  2015-07-14       Impact factor: 7.853

10.  Reversal of morphine analgesic tolerance by ethanol in the mouse.

Authors:  L C Hull; B H Gabra; C P Bailey; G Henderson; W L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2013-03-25       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.